Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 7 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced Monday that in phase 3 clinical trials ...
National Academies Issue New Broad Definition of Long COVID
Medscape· 7 days agoA new broadly inclusive definition of long COVID from the National Academies of Sciences,...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
Analysis | Court rejects abortion pill challenge, but what happens next?
Washington Post· 3 days agoWhat do you think is next in the fight over medication abortion? Today’s edition: Senate Republicans...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1 variant ...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 6 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 7 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, in an advanced clinical trial that included adults ages 50 ...